If it looks cloudy, foamy, or has visible particles, do not use it
Are you a weight loss dietitian supporting patients pre- and post-bariatric surgery, or while on a GLP-1 medication
p-Aminophenyl-alpha-D-mannopyranoside engineered lipidic nanoparticles for effective delivery of docetaxel to brain
Nissen observes, because studies of these drugs for obesity show that they reduce death due to various other causes. After median treatment of 47.4 months, the six-component cardiorenal end point occurred in 23.7% of tirzepatide-treated patients versus 27.4% of dulaglutide-treated patients, translating to a hazard ratio (HR) of 0.84 (95% CI, 0.79-0.90
This focus of this study was to determine if children affected with konzo had different plasma-based protein differences that may shed light on the mechanisms of the development of the disease
And again, that's very much an indi in individualized thing, but also helping them understand their role in the process